4362 — Nippon Fine Chemical Co Balance Sheet
0.000.00%
- ¥55bn
- ¥44bn
- ¥36bn
- 96
- 61
- 84
- 95
Annual balance sheet for Nippon Fine Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14,374 | 12,863 | 8,937 | 12,856 | 14,300 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,874 | 8,702 | 8,855 | 9,172 | 8,221 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28,929 | 30,224 | 29,591 | 32,031 | 32,214 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11,230 | 12,773 | 14,227 | 14,401 | 15,609 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 53,265 | 54,808 | 56,673 | 59,451 | 59,796 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,305 | 7,612 | 7,616 | 9,438 | 7,417 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 11,149 | 11,075 | 11,406 | 12,803 | 11,636 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 42,116 | 43,732 | 45,267 | 46,648 | 48,161 |
| Total Liabilities & Shareholders' Equity | 53,265 | 54,808 | 56,673 | 59,451 | 59,796 |
| Total Common Shares Outstanding |